IXEKIZUMAB (TaltzĀ®)

Clinical Indication

Axial spondyloarthritis

Comments

In line with NICE TA718

Implementation date 21st October

Date of classification

October 2021

Review date

October 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.